Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01896479
Title A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer
Recruitment Active, not recruiting
Gender both
Phase FDA approved
Variant Requirements Yes
Sponsors Exelixis
Indications

thyroid gland medullary carcinoma

Therapies

Cabozantinib

Age Groups: senior | adult
Covered Countries ITA | FRA | ESP | CAN

Facility Status City State Zip Country Details
St. Leonards New South Wales 2065 Australia Details
Herston Queensland 4006 Australia Details
Kurralta Park South Australia 5037 Australia Details
Heidelberg Victoria 3084 Australia Details
Parkville Victoria 3050 Australia Details
Québec Quebec JIH 5N4 Canada Details
Toronto M5G 2M9 Canada Details
Osijek 31000 Croatia Details
Zagreb 10000 Croatia Details
Zagreb 1000 Croatia Details
Bordeaux Gironde 33076 France Details
Angers Maine-et-Loire 49933 France Details
Lyon Rhône 69373 France Details
Villejuif Val-de-Marne 94805 France Details
Dijon 21079 France Details
Paris 75013 France Details
Strasbourg Cedex 67065 France Details
Budapest 1088 Hungary Details
Debrecen 4032 Hungary Details
Jerusalem 91120 Israel Details
Petach Tikva 49100 Israel Details
Safed 13100 Israel Details
Catania CT 95124 Italy Details
Roma RM 00161 Italy Details
Sienna SI 53100 Italy Details
Pisa Toscana 56124 Italy Details
Milano 20133 Italy Details
Padua 35138 Italy Details
Torino 10153 Italy Details
Goyang Gyeonggido 410769 Korea, Republic of Details
Seoul 110744 Korea, Republic of Details
Seoul 135-710 Korea, Republic of Details
Amsterdam Noord Holland 1066 CX Netherlands Details
Leiden Zuid-Holland 2333 ZA Netherlands Details
Groningen 9713 GZ Netherlands Details
Gliwice Slaskie 44-100 Poland Details
Poznań Wielkopolskie 60-355 Poland Details
Bucharest 10825 Romania Details
Bucharest 11863 Romania Details
Cluj-Napoca 400058 Romania Details
Timisoara 300723 Romania Details
Novosibirsk 630068 Russian Federation Details
Obninsk 249036 Russian Federation Details
St. Petersburg 197089 Russian Federation Details
Yaroslavl 150040 Russian Federation Details
Barcelona 08035 Spain Details
Madrid 28034 Spain Details
Madrid 28046 Spain Details
Lund Skane Ian SE-22185 Sweden Details
Uppsala Uppsala Ian 75185 Sweden Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field